The effect of cyclosporine G (OG37-325), cyclosporine A, and their metabolites on the release of vasoactive substances from primary renal cell lines.
Langman
L J
LJ
Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada.
Yatscoff
R W
RW
D000818:Animals; D001013:Aorta, Thoracic; D002460:Cell Line; D002478:Cells, Cultured; D016572:Cyclosporine / Q000378:metabolism / Q000494:pharmacology*; D003524:Cyclosporins / Q000494:pharmacology*; D016232:Endothelins / Q000096:biosynthesis* / Q000378:metabolism; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000502:physiology; D011464:Epoprostenol / Q000096:biosynthesis*; D005920:Glomerular Mesangium / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D011817:Rabbits; D013329:Structure-Activity Relationship
D003524:Cyclosporins; D016232:Endothelins; C045571:cyclosporin G; D016572:Cyclosporine; D011464:Epoprostenol